Download Leukaemia Section t(12;15)(p13;q25) Atlas of Genetics and Cytogenetics in Oncology and Haematology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Gene nomenclature wikipedia , lookup

Gene expression profiling wikipedia , lookup

Nicotinic acid adenine dinucleotide phosphate wikipedia , lookup

Protein moonlighting wikipedia , lookup

Epigenetics of human development wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Point mutation wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

Mir-92 microRNA precursor family wikipedia , lookup

BRAF (gene) wikipedia , lookup

NEDD9 wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Leukaemia Section
Short Communication
t(12;15)(p13;q25)
Jean-Loup Huret
Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
(JLH)
Published in Atlas Database: January 2008
Online updated version: http://AtlasGeneticsOncology.org/Anomalies/t1215p13q25ID1347.html
DOI: 10.4267/2042/44405
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2009 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Fusion protein
Clinics and pathology
Description
Encodes a fusion protein with the sterile alpha motif
(SAM) oligomerization domain of ETV6 in N-term to
the C- term protein tyrosine kinase (PTK) domain of
NTRK3.
Oncogenesis
Functions as a constitutively active tyrosine kinase.
ETV6-NTRK3 is capable of homodimerization, or
heterodimerization with ETV6, and subsequent PTK
activation, leading to constitutive elevation of cyclin
D1, and increased cell cycle progression. ETV6NTRK3 also leads to constitutive activation of two of
the major effector pathways of NTRK3: the RasMAPK mitogenic pathway and the phosphatidyl
inositol-3-kinase (PI3K) pathway leading to activation
of the AKT cell survival factor (Lannon and Sorensen,
2005).
Disease
Acute myeloid leukaemia (AML), FAB M2 subtype.
Epidemiology
Only one case to date, a 59-year-old female patient.
Prognosis
The patient died 5 months after the onset of the
leukaemia.
Cytogenetics
Additional anomalies
+8 and other anomalies.
Genes involved and proteins
ETV6
To be noted
Location
12p13
Protein
ETS-related transcription regulator.
Note
The same translocation t(12;15)(p13;q25) with the
same genes involved (ETV6-NTRK3) can also be
found in: Secretory Ductal Breast Carcinoma , in
Congenital Mesoblastic Nephroma, and in Congenital
Fibrosarcoma.
NTRK3
Location
15q25
Protein
Tyrosine kinase cell surface receptor.
References
Setoyama M, Tojo A, Nagamura F, Asano S, Ishimae M,
Eguchi M, Kamada N. A unique translocation of the TEL gene
in a case of acute myelogenous leukemia with inv(12)(p13q15)
Blood. 1998 Aug 15;92(4):1454-5
Result of the chromosomal
anomaly
Eguchi M, Eguchi-Ishimae M, Tojo A, Morishita K, Suzuki K,
Sato Y, Kudoh S, Tanaka K, Setoyama M, Nagamura F, Asano
S, Kamada N. Fusion of ETV6 to neurotrophin-3 receptor
TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood.
1999 Feb 15;93(4):1355-63
Hybrid gene
Description
5' ETV6-3' NTRK3
Atlas Genet Cytogenet Oncol Haematol. 2009; 13(2)
130
t(12;15)(p13;q25)
Huret JL
Lannon CL, Sorensen PH. ETV6-NTRK3: a chimeric protein
tyrosine kinase with transformation activity in multiple cell
lineages. Semin Cancer Biol. 2005 Jun;15(3):215-23
Atlas Genet Cytogenet Oncol Haematol. 2009; 13(2)
This article should be referenced as such:
Huret JL. t(12;15)(p13;q25). Atlas Genet Cytogenet Oncol
Haematol. 2009; 13(2):130-131.
131
Related documents
Leukaemia Section t(1;12)(q25;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;12)(q25;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;12)(q22;p12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;12)(q22;p12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section ABL2 (Abelson homolog 2) Atlas of Genetics and Cytogenetics
Gene Section ABL2 (Abelson homolog 2) Atlas of Genetics and Cytogenetics
Leukaemia Section t(2;13)(p16;q12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(2;13)(p16;q12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;12)(p36;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;12)(p36;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;5)(q25;q34)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;5)(q25;q34) Atlas of Genetics and Cytogenetics
Leukaemia Section t(5;17)(q33;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(5;17)(q33;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(5;11)(q33;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(5;11)(q33;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;12)(p24;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;12)(p24;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(4;12)(p16;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(4;12)(p16;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section MDS2 (myelodysplastic syndrome 2 translocation associated) Atlas of Genetics and Cytogenetics
Gene Section MDS2 (myelodysplastic syndrome 2 translocation associated) Atlas of Genetics and Cytogenetics
Leukaemia Section 12p13 rearrangements in treatment related leukemia Atlas of Genetics and Cytogenetics
Leukaemia Section 12p13 rearrangements in treatment related leukemia Atlas of Genetics and Cytogenetics
Leukaemia Section t(6;12)(p21;p13) in lymphoid malignancies Atlas of Genetics and Cytogenetics
Leukaemia Section t(6;12)(p21;p13) in lymphoid malignancies Atlas of Genetics and Cytogenetics
Gene Section JARID1A (jumonji, AT rich interactive domain 1A (RBBP2-like))
Gene Section JARID1A (jumonji, AT rich interactive domain 1A (RBBP2-like))
Gene Section CBLb (Cas-Br-M (murine) ecotropic retroviral transforming sequence b)
Gene Section CBLb (Cas-Br-M (murine) ecotropic retroviral transforming sequence b)
Gene Section AKAP9 (A kinase (PRKA) anchor protein (yotiao) 9)
Gene Section AKAP9 (A kinase (PRKA) anchor protein (yotiao) 9)
Leukaemia Section t(11;14)(p13;q11), t(7;11)(q35;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;14)(p13;q11), t(7;11)(q35;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(5;12)(p13;p1 3) NIPBL/ETV6 Atlas of Genetics and Cytogenetics
Leukaemia Section t(5;12)(p13;p1 3) NIPBL/ETV6 Atlas of Genetics and Cytogenetics
Gene Section MNX1 (motor neuron and pancreas homeobox 1)
Gene Section MNX1 (motor neuron and pancreas homeobox 1)
Leukaemia Section t(1;14)(q25;q32) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;14)(q25;q32) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;12)(q34;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;12)(q34;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section PTPN21 (protein tyrosine phosphatase, non- receptor type 21)
Gene Section PTPN21 (protein tyrosine phosphatase, non- receptor type 21)